Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses

NACompletedINTERVENTIONAL
Enrollment

455

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2019

Study Completion Date

April 30, 2021

Conditions
Coronary Artery Disease
Interventions
OTHER

Percutaneous coronary intervention (PCI)

For lesions with both FFR\<=0.8 and CFR\<2.0

OTHER

Optimal medical therapy (OMT)

For lesions with FFR\>0.8 or CFR\>=2.0 or both

Trial Locations (12)

Unknown

Aarhus University Hospital, Aarhus

Catholic University of the Sacred Heart, Rome

Gifu Heart Center, Gifu

Toda Central General Hospital, Toda

Tokyo Medical University, Tokyo

Tsuchiura Kyodo, Tsuchiura

Amsterdam UMC - location AMC, Amsterdam

Amsterdam UMC - location VUmc, Amsterdam

Tergooi Hospital, Blaricum

Amphia Hospital, Breda

Hospital Clinico San Carlos, Madrid

Royal Free Hospital, London

All Listed Sponsors
collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

Volcano Corporation

INDUSTRY

lead

The University of Texas Health Science Center, Houston

OTHER

NCT02328820 - Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses | Biotech Hunter | Biotech Hunter